21.04.2015 08:22 Uhr in Kultur & Kunst von -
740x141 Pixel - Dateigröße: 408,43 Kb
(Mynewsdesk) * GATC Biotech to play an essential role in the commercialisation of TreatmentMAPTM
* Significantly increased access to the first registered medical device for personalised cancer medicine in Europe
* GATC Biotech expands the market reach and opportunities of its Diagnostic Solutions division
Constance, Germany, 21 April 2015: GATC Biotech, provider of innovative, high quality DNA and RNA sequencing solutions to the pharmaceutical and diagnostics markets, announced today that it ... ... weiter lesen Quelle
* Significantly increased access to the first registered medical device for personalised cancer medicine in Europe
* GATC Biotech expands the market reach and opportunities of its Diagnostic Solutions division
Constance, Germany, 21 April 2015: GATC Biotech, provider of innovative, high quality DNA and RNA sequencing solutions to the pharmaceutical and diagnostics markets, announced today that it ... ... weiter lesen Quelle
Pressefach abonnieren
via RSS-Feed abonnieren
via E-Mail abonnieren
Pressekontakt
Dr. Helge Schnerr
-
Jakob-Stadler-Platz 7
78467 Konstanz
-
Drucken
Weiterempfehlen
PDF
Schlagworte
Permanentlinks
https://www.prmaximus.de/124012-
Jakob-Stadler-Platz 7
78467 Konstanz
-
https://www.prmaximus.de/pressefach/-pressefach.html
Die Pressemeldung "GATC Biotech signs a sales and marketing agreement for products and services with Molecular Health" unterliegt dem Urheberrecht.
Jegliche Verwendung dieses Textes, auch auszugsweise, erfordert die vorherige schriftliche Erlaubnis des Autors.
Autor der Pressemeldung "GATC Biotech signs a sales and marketing agreement for products and services with Molecular Health" ist -, vertreten durch Dr. Helge Schnerr.